Children's Hospital Colorado
Select a category:

Showing 551-560 of 6394
Articles

Demystifying a Novel Disease

Through whole-genome sequencing, immunologists identified a novel genetic mutation and unlocked information critical to treating a patient’s rare disease –– Pneumocystis jirovecii pneumonia.

Articles

MRI Findings Following Button Battery Ingestion

According this this study, MRI can be a valuable tool for guiding clinical management of patients who ingested button batteries. Learn more.

Articles

Clinical Trial: Dual-Attack CAR T-Cell Therapy for Pediatric Acute Lymphoblastic Leukemia

Learn about the CAR T-cell product targeted at ALL surface proteins CD19 and CD22 that Children’s Colorado researchers are manufacturing on-site.

Articles

Insulin-like Growth Factor-1 Infusion to Fetal Sheep Increases Organ Growth

Researchers sought to determine the effect of a one-week fetal infusion of LR3 IGF-1 in late gestation fetal sheep.

Articles

Analysis of Patient and Family Psychosocial Functioning in Colorectal Conditions

Read about our researchers’ analysis of the psychosocial functioning of caregivers and patients with colorectal conditions, which included a comparison of diagnosis, gender and developmental functioning.

Articles

Early-Onset Type 2 Diabetes: A Deeper Understanding

TODAY2 researchers followed kids and adolescents with early-onset type 2 diabetes for more than 15 years. Learn about their findings.

Articles

ESPNIC Consensus Statement on Recommendations for Hemodynamic Monitoring for Critically Ill Children

Learn how experts from the Heart Institute at Children’s Hospital Colorado helped create international recommendations for hemodynamic monitoring for critically ill children.

Articles

CFTR Modulator Therapy for Young Children with Cystic Fibrosis

A clinical trial evaluated the safety and efficacy of the CFTR modulator therapy elexacaftor/tezacaftor/ivacaftor in children as young as 6 with a common form of cystic fibrosis.

Articles

Safety of Lumacaftor-Ivacaftor for Young Children with Cystic Fibrosis

Our pediatric pulmonologist led a study that investigated the safety and efficacy of long-term lumacaftor-ivacaftor treatment in kids 2 to 5 years old with cystic fibrosis homozygous for the F508del-CFTR mutation. Learn about the study findings.

Articles

Overview of Study of Highly Effective CFTR Modulator Therapy for Cystic Fibrosis

Children’s Colorado researchers are studying if and how the highly effective CFTR modulator therapy might improve organ systems affected by CF.